公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2009 | Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses | CHUN-JEN LIU ; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; CHI-LING CHEN ; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO ; CHEN-HUA LIU ; Su W.; Lin C.; YUNG-MING JENG ; PEI-JER CHEN ; DING-SHINN CHEN | Gastroenterology | 182 | 157 | |
2021 | Pharmacokinetics, safety, and efficacy of trastuzumab deruxtecan with concomitant ritonavir or itraconazole in patients with HER2-expressing advanced solid tumors | Takahashi S.; Karayama M.; Takahashi M.; Watanabe J.; Minami H.; Yamamoto N.; Kinoshita I.; CHIA-CHI LIN ; Im Y.-H.; Achiwa I.; Kamiyama E.; Okuda Y.; Lee C.; Bang Y.-J. | Clinical Cancer Research | 14 | 11 | |
2020 | Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learning | Kang J.S.; Lee C.; Song W.; Choo W.; Lee S.; Lee S.; Han Y.; Bassi C.; Salvia R.; Marchegiani G.; Wolfgang C.L.; He J.; Blair A.B.; Kluger M.D.; Su G.H.; Kim S.C.; Song K.-B.; Yamamoto M.; Higuchi R.; Hatori T.; CHING-YAO YANG ; Yamaue H.; Hirono S.; Satoi S.; Fujii T.; Hirano S.; Lou W.; Hashimoto Y.; Shimizu Y.; Del Chiaro M.; Valente R.; Lohr M.; Choi D.W.; Choi S.H.; Heo J.S.; Motoi F.; Matsumoto I.; Lee W.J.; Kang C.M.; Shyr Y.-M.; Wang S.-E.; Han H.-S.; Yoon Y.-S.; Besselink M.G.; van Huijgevoort N.C.M.; Sho M.; Nagano H.; Kim S.G.; Honda G.; Yang Y.; Yu H.C.; Do Yang J.; Chung J.C.; Nagakawa Y.; Seo H.I.; Choi Y.J.; Byun Y.; Kim H.; Kwon W.; Park T.; Jang J.-Y. | Scientific Reports | 10 | 10 | |
2018 | Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: Week 52 results from SPIRIT-P2 | Genovese M.C.; Combe B.; Kremer J.M.; TSEN-FANG TSAI ; Behrens F.; Adams D.H.; Lee C.; Kerr L.; Nash P. | Rheumatology (United Kingdom) | 35 | 33 |